International Biotechnology (LON:IBT - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 625.96 ($8.27) and traded as high as GBX 652 ($8.61). International Biotechnology shares last traded at GBX 644 ($8.51), with a volume of 54,213 shares changing hands.
International Biotechnology Price Performance
The business has a fifty day moving average of GBX 607.49 and a 200 day moving average of GBX 625.82. The stock has a market cap of £228.46 million, a price-to-earnings ratio of 6.07 and a beta of 0.21.
International Biotechnology (LON:IBT - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported GBX (5.60) (($0.07)) EPS for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. On average, analysts expect that International Biotechnology will post 0.9435943 EPS for the current year.
Insider Transactions at International Biotechnology
In other International Biotechnology news, insider Katherine Cornish-Bowden bought 2,000 shares of the stock in a transaction on Tuesday, May 13th. The shares were purchased at an average cost of GBX 585 ($7.73) per share, with a total value of £11,700 ($15,455.75). Corporate insiders own 4.18% of the company's stock.
About International Biotechnology
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Featured Stories
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
